MoonLake announces significant improvements with Nanobody® sonelokimab over 24 weeks in active psoriatic arthritis (PsA) and other important updates at.
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average twelve-month target […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has received a consensus rating of “Moderate Buy” from the twelve brokerages that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1-year price target among brokers that […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) insider Kristian Reich sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $57.43, for a total value of $574,300.00. Following the completion of the transaction, the insider now directly owns 100,071 shares […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) CEO Da Silva Jorge Santos sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $57.44, for a total transaction of $1,148,800.00. Following the transaction, the chief executive officer now owns 3,107,554 shares […]